Cost-effectiveness of rotavirus vaccination in Albania
详细信息 查看全文
- 作者：Albana Ahmetia ; albiahmeti@yahoo.com" class="auth_mail" title="E-mail the corresponding author ; Iria Prezaa ; Artan Simakua ; Erida Nelaja ; Andrew David Clarkb ; Ana Gabriela Felix Garciac ; Carlos Larad ; Cé ; line Hoestlandtd ; Julia Blaud ; Silvia Binoa
- 关键词：Albania ; Cost-effectiveness ; Diarrhea ; Evidenced-based medicine ; Rotavirus ; Vaccine
- 刊名：Vaccine
- 出版年：2015
- 出版时间：7 May 2015
- 年：2015
- 卷：33
- 期：supp_S1
- 页码：A201-A208
- 全文大小：1116 K
文摘
- •
Rotavirus RV1 and RV5 vaccines would avert 51,172 outpatient visits and 14,200 hospitalizations.
- •
Each vaccine would avert a total of 27 deaths, 950 DALYs and gain 801 life years.
- •
Total cost of RV1 and RV5 vaccines would be US$ 5.77 and US$ 8.66 million, respectively.
- •
Introduction of RV1 vaccine would be a highly cost-effective approach in Albania.